Meeting
2020 ASCO Virtual Scientific Program
Carboplatin versus cisplatin for the treatment of extensive-stage small cell lung cancer (SCLC): A National VA Database analysis.
Authors
Ibrahim Azar
Karmanos Cancer Institute, Detroit, MI
Ibrahim Azar , Adam Austin , Seongho Kim , Hyejeong Jang , Amit Chopra , Syed Arzoo Mehdi , Hirva Mamdani
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Small Cell Lung Cancer
Citation
J Clin Oncol 38: 2020 (suppl; abstr 9061)
DOI
10.1200/JCO.2020.38.15_suppl.9061
Abstract #
9061
Poster Bd #
254
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
COCIS individual patient data (IPD) meta-analysis: Carboplatin- or cisplatin-based chemotherapy (CT) as first-line treatment of small cell lung cancer (SCLC).
First Author: A. Rossi
Poster
2023 ASCO Genitourinary Cancers Symposium
Atezolizumab with platinum and etoposide chemotherapy followed by cystectomy for patients with localized small cell neuroendocrine bladder cancer.
First Author: Jean H. Hoffman-Censits
Poster
2019 Genitourinary Cancers Symposium
Real-world trends in first-line checkpoint inhibitor use (CPI) in advanced urothelial cell carcinoma (aUC).
First Author: Ravi Bharat Parikh